ASPO Session to Cover Sensorion Audiogene Trial of Pediatric Therapy for Hearing Loss
Sensorion will present early clinical trial results of its gene therapy SENS-501 for treating severe pediatric hearing loss at the 2025 ASPO meeting.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
